Verification of quantitative polymerase chain reaction method for monitoring minimal residual disease in chronic myeloid leukemia

Autor: Tkalčić Švabek, Ž., Kardum Paro, M.M., Horvat, M., Mandac Smoljanović, I., Martinović, M., Radić Krišto, D.

Publikováno v: In Clinica Chimica Acta 1 May 2024 558 Supplement 1

Primary Bone Lymphoma of the Scapula.

Autor: Lovaković J; Department of Surgery, University Hospital Center Zagreb, 10 000 Zagreb, Croatia., Mandac Smoljanović I; Department of Internal Medicine, University Hospital Merkur, School of Medicine, University of Zagreb, 10 000 Zagreb, Croatia., Matković A; Clinical Department for Diagnostic and Interventional Radiology, University Hospital Merkur, 10 000 Zagreb, Croatia., Smoljanović T; Department of Orthopaedic Surgery, University Hospital Center Zagreb, School of Medicine, University of Zagreb, 10 000 Zagreb, Croatia.

Publikováno v: Hematology reports [Hematol Rep] 2024 Feb 28; Vol. 16 (1), pp. 106-113. Date of Electronic Publication: 2024 Feb 28.

Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review.

Autor: Milunović V; Division of Hematology, Clinical Hospital Merkur, 10000 Zagreb, Croatia., Hude I; Division of Hematology, Clinical Hospital Centre Zagreb, 10000 Zagreb, Croatia., Rinčić G; Division of Hematology, Clinical Hospital Centre Sestre Milosrdnice, 10000 Zagreb, Croatia., Galušić D; Division of Hematology, Clinical Hospital Center Split, 21000 Split, Croatia.; School of Medicine, University of Split, 21000 Split, Croatia., Grubešić A; Division of Hematology, Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia.; School of Medicine, University of Rijeka, 51000 Rijeka, Croatia., Martinović M; Division of Hematology, Clinical Hospital Merkur, 10000 Zagreb, Croatia., Popović N; Division of Hematology and Oncology, General Hospital, 42000 Varaždin, Croatia., Divošević S; Policlinic Medikol, 10000 Zagreb, Croatia., Brčić K; Division of Hematology, Clinical Hospital Centre Sestre Milosrdnice, 10000 Zagreb, Croatia., Međugorac M; Division of Hematology, Clinical Hospital Sveti Duh, 10000 Zagreb, Croatia., Kužat L; Division of Oncology and Hematology, General Hospital Čakovec, 40000 Čakovec, Croatia., Strahija D; Division of Hematology and Oncology, General Hospital, 42000 Varaždin, Croatia., Mrđenović S; Division of Hematology, Clinical Hospital Center, 31000 Osijek, Croatia.; School of Medicine, University of Osijek, 31000 Osijek, Croatia., Mandac Smoljanović I; Division of Hematology, Clinical Hospital Merkur, 10000 Zagreb, Croatia.; Clinical Department of Pathology and Cytology, Clinical Hospital Merkur, 10000 Zagreb, Croatia.; School of Medicine, University of Zagreb, 10000 Zagreb, Croatia., Radić-Krišto D; Division of Hematology, Clinical Hospital Merkur, 10000 Zagreb, Croatia.; Clinical Department of Pathology and Cytology, Clinical Hospital Merkur, 10000 Zagreb, Croatia.; School of Medicine, University of Zagreb, 10000 Zagreb, Croatia., Gašparov S; Division of Oncology and Hematology, General Hospital Čakovec, 40000 Čakovec, Croatia.; Clinical Department of Pathology and Cytology, Clinical Hospital Merkur, 10000 Zagreb, Croatia.; School of Medicine, University of Zagreb, 10000 Zagreb, Croatia., Aurer I; Division of Hematology, Clinical Hospital Centre Zagreb, 10000 Zagreb, Croatia.; Clinical Department of Pathology and Cytology, Clinical Hospital Merkur, 10000 Zagreb, Croatia.; School of Medicine, University of Zagreb, 10000 Zagreb, Croatia., Ostojić Kolonić S; Division of Hematology, Clinical Hospital Merkur, 10000 Zagreb, Croatia.; Division of Hematology, Clinical Hospital Center Split, 21000 Split, Croatia.; School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.

Publikováno v: Biomedicines [Biomedicines] 2022 Nov 14; Vol. 10 (11). Date of Electronic Publication: 2022 Nov 14.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes

Autor: Arjan A. van de Loosdrecht, Inga Mandac Smoljanović

Publikováno v: van de Loosdrecht, A A & Mandac Smoljanović, I 2022, ' EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes ', HemaSphere, vol. 6, no. 3, pp. E695 . https://doi.org/10.1097/HS9.0000000000000695
HemaSphere, 6(3). Wolters Kluwer Health

European Hematology Association (EHA) and European Society for Medical Oncology (ESMO) recently agreed to collaborate on the production of European Guidelines for different hematological malignancies. As a first step, a number of completed guidelines

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdac89bfb96f0d3f0cfb53ab5ba3f3fb
https://research.vumc.nl/en/publications/e307f0a2-fff7-4340-9719-a75268655889